
LitCapital sells MPG to PE-backed Affidea
Lithuanian growth capital firm LitCapital has sold its stake in healthcare service provider Medicinos Paslaugų Grupė (MPG) to Waypoint Capital-backed Affidea.
It is the fifth exit from LitCapital I, a €25m fund that was launched in 2010 to make investments of €1-3m in Lithuanian businesses.
Revenues increased nearly by 50% and EBITDA grew by 5x during the ownership of LitCapital, according to a statement.
The acquirer is backed by Waypoint Capital (formerly Ares Life Sciences), which acquired the company from Montagu Private Equity in 2014.
Previous funding
LitCapital invested in MPG in 2015 and supported the bolt on of Lithuanian laboratory Endemik.
Company
MPG was founded in 2010 and is headquartered in Vilnius. It operates eight clinics across Lithuania providing services such as vaccination, laboratory diagnostics, radiology examination and GP consultation. It employs 180 people.
Advisers
Vendor – Swedbank Investment Banking Lithuania (corporate finance); TGS Baltic (legal).
Acquirer – Walless (legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater